Argent Trust Co Buys 445 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Argent Trust Co grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,221 shares of the medical equipment provider’s stock after purchasing an additional 445 shares during the quarter. Argent Trust Co’s holdings in Intuitive Surgical were worth $5,335,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock traded down $29.65 during midday trading on Thursday, hitting $493.30. The stock had a trading volume of 578,246 shares, compared to its average volume of 1,578,420. The business has a 50-day moving average of $536.22 and a two-hundred day moving average of $532.26. The firm has a market cap of $175.70 billion, a price-to-earnings ratio of 76.96, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.